Published in J Immunol on May 01, 1982
The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med (1983) 7.55
Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med (1983) 6.97
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92
The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J Exp Med (1984) 4.29
The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med (1983) 3.54
Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol (2010) 2.80
Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci U S A (1984) 2.80
The major histocompatibility complex-restricted antigen receptor on T cells. IV. An antiidiotypic antibody predicts both antigen and I-specificity. J Exp Med (1983) 2.03
Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proc Natl Acad Sci U S A (2010) 1.87
Helper signals in the plaque-forming cell response to protein-bound haptens. J Exp Med (1983) 1.43
Antigen-specific, H-2-restricted helper T cell hybridomas. J Exp Med (1982) 1.29
The beta 1 domain of the mouse E beta chain is important for restricted antigen presentation to helper T-cell hybridomas. Proc Natl Acad Sci U S A (1985) 1.21
Ia-transfected L-cell fibroblasts present a lysozyme peptide but not the native protein to lysozyme-specific T cells. Proc Natl Acad Sci U S A (1985) 1.21
Lysis of inducer T cell clones by activated macrophages and macrophage-like cell lines. J Exp Med (1983) 1.07
Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med (2003) 1.05
Functional and inducible expression of a transfected murine class II major histocompatibility complex gene. Proc Natl Acad Sci U S A (1984) 1.05
Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma. J Exp Med (1989) 0.96
MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation. J Exp Med (1990) 0.93
Characterization of immortalized MARCO and SR-AI/II-deficient murine alveolar macrophage cell lines. Part Fibre Toxicol (2008) 0.93
Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing. Proc Natl Acad Sci U S A (1989) 0.89
Antigen presentation by liposomes bearing class II MHC and membrane IL-1. Yale J Biol Med (1990) 0.85
The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc Natl Acad Sci U S A (2001) 0.84
B cells do not present antigen covalently linked to microspheres. Immunology (1993) 0.84
Impaired protein catabolism in Trypanosoma cruzi-infected macrophages: possible involvement in antigen presentation. Immunology (1995) 0.83
Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition. J Exp Med (1997) 0.83
Endopeptidase activities associated with the plasma membrane compartment of an antigen-presenting B cell. Clin Exp Immunol (1989) 0.81
Presentation of a soluble bacterial antigen and cell-surface alloantigens by large granular lymphocytes (LGL) in comparison with monocytes. Immunology (1986) 0.79
Activation of idiotype-specific CD4+ T-cell line: cellular processing of exogenous self-immunoglobulin. Immunology (1990) 0.75
Warner-Lambert/Parke-Davis award lecture. Cellular interactions in the immune response. The roles of B lymphocytes and interleukin-4. Am J Pathol (1987) 0.75
Purified human NK cells do not function as accessory cells in T-cell proliferative responses. Immunology (1988) 0.75
Characteristics of spontaneously proliferating mononuclear cells in rheumatoid arthritis. Ann Rheum Dis (1984) 0.75
T cell tolerance by clonal elimination in the thymus. Cell (1987) 13.83
Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med (1981) 12.03
The staphylococcal enterotoxins and their relatives. Science (1990) 11.99
Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90
Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. J Immunol (1989) 8.19
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Sulphydryl groups in proteins. Biochem J (1937) 7.82
A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry (1996) 7.80
The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med (1983) 7.55
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A (1989) 7.48
The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell (1989) 7.02
Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med (1983) 6.97
Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol (1983) 6.39
Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science (2000) 6.22
Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol (2001) 6.19
Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol (1991) 5.71
V beta-specific stimulation of human T cells by staphylococcal toxins. Science (1989) 5.34
A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63
Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry (1999) 4.57
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Rate of Liberation of Acid by betabeta'-Dichlorodiethyl Sulphide and its Analogues in its Relation to the "Acid" Theory of Skin Vesication. Biochem J (1923) 4.50
The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature (1988) 4.43
The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype. J Exp Med (1984) 4.29
Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol (1983) 4.24
T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med (2000) 4.16
Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity (1998) 4.15
Interleukin-induced increase in Ia expression by normal mouse B cells. J Exp Med (1984) 4.14
A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product. Cell (1987) 4.09
The T cell receptor. Science (1987) 4.00
Type I interferons keep activated T cells alive. J Exp Med (1999) 3.98
Observation of antigen-dependent CD8+ T-cell/ dendritic cell interactions in vivo. Cell Immunol (2001) 3.91
Superantigens and their potential role in human disease. Adv Immunol (1993) 3.88
Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol (1984) 3.72
Evidence for the effects of a superantigen in rheumatoid arthritis. Science (1991) 3.71
The role of the T cell receptor in positive and negative selection of developing T cells. Science (1990) 3.64
Ionizing radiation and the immune response. Adv Immunol (1976) 3.58
The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med (1983) 3.54
A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature (1991) 3.47
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol (1993) 3.42
Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas. Proc Natl Acad Sci U S A (1982) 3.41
B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor. J Exp Med (1981) 3.40
Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA (1997) 3.36
Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma (1982) 3.36
The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med (1990) 3.31
The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care (1995) 3.29
Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28
Superantigens interact with MHC class II molecules outside of the antigen groove. Cell (1990) 3.20
An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 3.15
The immunoglobulin nature of the antigen recognition site on cells mediating transplantation immunity and delayed hypersentivity. J Immunol (1970) 3.08
A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst (1969) 3.06
Autoimmune disease: why and where it occurs. Nat Med (2001) 3.04
The repertoire of T cells shaped by a single MHC/peptide ligand. Cell (1996) 3.04
Concanavalin A-inducible, interleukin-2-producing T cell hybridoma. J Exp Med (1980) 3.02
Membrane immunoglobulins and antigen receptors on B and T lymphocytes. Adv Immunol (1974) 2.99
Production of soluble MHC class II proteins with covalently bound single peptides. Nature (1994) 2.98
Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med (1998) 2.97
Primary structure of human T-cell receptor alpha-chain. Nature (1985) 2.93
A maternally inherited superantigen encoded by a mammary tumour virus. Nature (1991) 2.92
Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature (1987) 2.89
Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity (1999) 2.84
Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci U S A (1984) 2.80
Two better cell lines for making hybridomas expressing specific T cell receptors. J Immunol (1989) 2.78
Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol (2001) 2.76
Blocking of the lymphocyte antigen receptor site with anti-immunoglobulin sera in vitro. Nature (1970) 2.74
Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A (1989) 2.73
Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A (1998) 2.71
Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med (1990) 2.71
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70
Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med (1991) 2.69
The major histocompatibility complex-restricted antigen receptor on T cells: distribution on thymus and peripheral T cells. Cell (1984) 2.64
Regulators of aerobic and anaerobic respiration in Bacillus subtilis. J Bacteriol (1996) 2.63
Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature (1990) 2.60